Skip to main content

Table 5 NPC mortality in China in 2013

From: Nasopharyngeal carcinoma incidence and mortality in China, 2013

Areas Sex CR (1/105) Prop (%) ASMRC (1/105) ASMRW (1/105) Cum rate (%) TASR (1/105) Rank
All Both 1.57 0.96 1.10 1.08 0.12 2.09 18
Male 2.26 1.12 1.63 1.60 0.19 3.10 13
Female 0.84 0.68 0.58 0.56 0.06 1.06 18
Urban areas Both 1.61 1.00 1.09 1.07 0.12 2.10 19
Male 2.38 1.21 1.65 1.62 0.19 3.16 14
Female 0.81 0.65 0.54 0.52 0.06 1.01 19
Rural areas Both 1.51 0.91 1.12 1.09 0.13 2.08 18
Male 2.12 1.02 1.62 1.58 0.18 3.02 12
Female 0.87 0.71 0.63 0.61 0.07 2.13 16
Eastern areas Both 1.62 0.86 1.02 1.00 0.12 3.27 17
Male 2.35 1.01 1.51 1.49 0.18 0.95 13
Female 0.87 0.61 0.53 0.52 0.06 2.02 18
Middle areas Both 1.41 0.91 1.06 1.03 0.11 2.98 19
Male 2.05 1.06 1.59 1.55 0.17 1.03 13
Female 0.75 0.64 0.54 0.53 0.06 3.21 18
Western areas Both 2.15 1.38 1.63 1.59 0.18 4.82 15
Male 3.07 1.54 2.36 2.29 0.27 1.55 10
Female 1.20 1.07 0.91 0.89 0.10 2.13 15
  1. CR crude rate, Prop proportion, ASMRC age-standardized mortality rate by Chinese standard population, ASMRW, age-standardized mortality rate by 1985 Segi’s world standard population, Cum rate cumulative rate for patients aged 0–74 years, TASR truncated age-standardized rate for patients aged 35–64 years, Rank rank of NPC mortality in all cancers’ mortalities